Alnylam Pharmaceuticals Inc (ALNY)
152.33
+2.02
(+1.34%)
USD |
NASDAQ |
May 03, 16:00
152.43
+0.10
(+0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Max Drawdown (5Y): 52.27% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 52.27% |
March 31, 2024 | 54.98% |
February 29, 2024 | 55.66% |
January 31, 2024 | 55.66% |
December 31, 2023 | 55.66% |
November 30, 2023 | 55.66% |
October 31, 2023 | 55.66% |
September 30, 2023 | 57.81% |
August 31, 2023 | 57.81% |
July 31, 2023 | 57.81% |
June 30, 2023 | 57.81% |
May 31, 2023 | 57.81% |
April 30, 2023 | 57.81% |
March 31, 2023 | 57.81% |
February 28, 2023 | 57.81% |
January 31, 2023 | 57.81% |
December 31, 2022 | 57.81% |
November 30, 2022 | 57.81% |
October 31, 2022 | 57.81% |
September 30, 2022 | 57.81% |
August 31, 2022 | 57.81% |
July 31, 2022 | 57.81% |
June 30, 2022 | 57.81% |
May 31, 2022 | 57.81% |
April 30, 2022 | 57.81% |
Date | Value |
---|---|
March 31, 2022 | 57.81% |
February 28, 2022 | 62.08% |
January 31, 2022 | 65.58% |
December 31, 2021 | 65.58% |
November 30, 2021 | 70.84% |
October 31, 2021 | 73.42% |
September 30, 2021 | 73.42% |
August 31, 2021 | 77.36% |
July 31, 2021 | 77.36% |
June 30, 2021 | 77.36% |
May 31, 2021 | 77.36% |
April 30, 2021 | 77.36% |
March 31, 2021 | 77.36% |
February 28, 2021 | 77.36% |
January 31, 2021 | 77.36% |
December 31, 2020 | 77.36% |
November 30, 2020 | 77.36% |
October 31, 2020 | 77.36% |
September 30, 2020 | 77.36% |
August 31, 2020 | 77.36% |
July 31, 2020 | 77.36% |
June 30, 2020 | 77.36% |
May 31, 2020 | 77.36% |
April 30, 2020 | 77.36% |
March 31, 2020 | 77.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
52.27%
Minimum
Apr 2024
77.36%
Maximum
May 2019
67.68%
Average
72.13%
Median
Max Drawdown (5Y) Benchmarks
Ionis Pharmaceuticals Inc | 70.27% |
Pfizer Inc | 54.78% |
Blueprint Medicines Corp | 69.50% |
BridgeBio Pharma Inc | -- |
Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 3.405 |
Beta (5Y) | 0.409 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 46.61% |
Historical Sharpe Ratio (5Y) | 0.1708 |
Historical Sortino (5Y) | 0.3571 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.81% |